This website is for UK healthcare professionals and UK healthcare decision makers only

Reporting adverse events
A
A
Prescribing information for:

Ferinject 
(ferric carboxymaltose)

Kapruvia ▼
(difelikefalin)

Tavneos ▼
(avacopan)

Veltassa 
(patiromer)

Venofer 
(iron sucrose)

Educational webinars, organised and funded by Vifor, and run by
experts in cardiology and nephrology to help support the
management of patients with HF and CKD

FERINJECT®
(ferric carboxymaltose)

KAPRUVIA®(difelikefalin)

TAVNEOS®(avacopan)

VELTASSA®
(patiromer)

WEBINARS
AND EVENTS

RELATED VIDEOS
PATIENT BLOOD MANAGEMENT: THE CURRENT PARADIGM SHIFT
Find out more play-icon

PATIENT BLOOD MANAGEMENT: THE CURRENT PARADIGM SHIFT

Professor Hofmann discusses the evidence supporting patient blood management of patients with anaemia, iron deficiency, blood loss or coagulopathy and asks whether there should be a paradigm shift away from a reliance on allogeneic blood transfusion, where the underlying cause of the patient’s condition is not always investigated.

UK-NA-2200217 January 2023

HEART FAILURE IN NORTHERN IRELAND
Find out more play-icon

HEART FAILURE IN NORTHERN IRELAND

Dr Patricia Campbell, Dr Alicja Jasinska-Piadlo and Edith Donnelly discuss the current landscape for heart failure patients in Northern Ireland and improvements for successful patient management through the latest guidance and interactive patient case studies.

UK-FCM-2300008 February 2023

OPTIMISING TREATMENTS FOR CARDIO-RENAL PATIENTS
Find out more play-icon

OPTIMISING TREATMENTS FOR CARDIO-RENAL PATIENTS

Professor Indranil Dasgupta, Jacqueline Elson-Whittaker, Lauren Dight, Dr Suresh Ramadoss and Dr Jim Moore give a multidisciplinary view on the long- and short-term management of hyperkalaemia, the challenges of diet and the role of primary care in the management of patients with kidney disease and associated co-morbidities such as heart failure.

UK-PAT-2300009 February 2023

All webinar
  • ALL WEBINARS
  • CKD
  • HEART FAILURE
  • PRE-OPERATIVE ANAEMIA
All webinars

PATIENT BLOOD MANAGEMENT: THE CURRENT PARADIGM SHIFT

Professor Hofmann discusses the evidence supporting patient blood management of patients with anaemia, iron deficiency, blood loss or coagulopathy and asks whether there should be a paradigm shift away from a reliance on allogeneic blood transfusion, where the underlying cause of the patient’s condition is not always investigated.

UK-NA-2200217 January 2023

HEART FAILURE IN NORTHERN IRELAND

Dr Patricia Campbell, Dr Alicja Jasinska-Piadlo and Edith Donnelly discuss the current landscape for heart failure patients in Northern Ireland and improvements for successful patient management through the latest guidance and interactive patient case studies.

UK-FCM-2300008 February 2023

OPTIMISING TREATMENTS FOR CARDIO-RENAL PATIENTS

Professor Indranil Dasgupta, Jacqueline Elson-Whittaker, Lauren Dight, Dr Suresh Ramadoss and Dr Jim Moore give a multidisciplinary view on the long- and short-term management of hyperkalaemia, the challenges of diet and the role of primary care in the management of patients with kidney disease and associated co-morbidities such as heart failure.

UK-PAT-2300009 February 2023

CKD

OPTIMISING TREATMENTS FOR CARDIO-RENAL PATIENTS

Professor Indranil Dasgupta, Jacqueline Elson-Whittaker, Lauren Dight, Dr Suresh Ramadoss and Dr Jim Moore give a multidisciplinary view on the long- and short-term management of hyperkalaemia, the challenges of diet and the role of primary care in the management of patients with kidney disease and associated co-morbidities such as heart failure.

UK-PAT-2300009 February 2023

HEART FAILURE

HEART FAILURE IN NORTHERN IRELAND

Dr Patricia Campbell, Dr Alicja Jasinska-Piadlo and Edith Donnelly discuss the current landscape for heart failure patients in Northern Ireland and improvements for successful patient management through the latest guidance and interactive patient case studies.

UK-FCM-2300008 February 2023

PRE-OPERATIVE ANAEMIA

PATIENT BLOOD MANAGEMENT: THE CURRENT PARADIGM SHIFT

Professor Hofmann discusses the evidence supporting patient blood management of patients with anaemia, iron deficiency, blood loss or coagulopathy and asks whether there should be a paradigm shift away from a reliance on allogeneic blood transfusion, where the underlying cause of the patient’s condition is not always investigated.

UK-NA-2200217 January 2023

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Vifor Pharma UK Ltd. (Tel 01276 853633). Email: medicalinfo_UK@viforpharma.com
More Resources

Webinars and events

Resources

Veltassa

Resources

Ferinject

Resources

You are now heading to a third-party website that we do
not operate. We are not responsible for the content of the
third-party website. You are advised to review its privacy policy
as it may differ from ours.

 

Are you sure you want to leave?

Confirm

Cancel

Report adverse events in the UK:

Adverse events should be reported. Reporting forms and information for United Kingdom can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Vifor Pharma Ltd. Tel: +44 1276 853633. E-mail: medicalInfo_UK@viforpharma.com